NCT04922710

Brief Summary

PEACH is a pilot project which is being conducted to determine the feasibility and acceptability of a 12-week home-based exercise intervention among Black and African American adults. A secondary aim of the project is to determine whether the exercise intervention improves cognitive and psychological functioning.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for early_phase_1

Timeline
Completed

Started Jan 2022

Geographic Reach
2 countries

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 11, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

January 4, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 3, 2023

Completed
27 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2023

Completed
1 year until next milestone

Results Posted

Study results publicly available

June 6, 2024

Completed
Last Updated

June 6, 2024

Status Verified

May 1, 2024

Enrollment Period

1.3 years

First QC Date

June 8, 2021

Results QC Date

March 15, 2024

Last Update Submit

May 9, 2024

Conditions

Keywords

Adverse Childhood ExperiencesBrain HealthCognitive AgingExerciseReversibility Network

Outcome Measures

Primary Outcomes (1)

  • Adherence to Exercise Intervention Program: Average Minutes Spent in Moderate to Vigorous Exercise

    Data regarding the average number of minutes spent engaging in moderate to vigorous exercise (via heart rate monitoring and comparison of heart rate to calculations based on heart rate reserve) will be collected to operationalize adherence. Adherence will be used as a metric of feasibility and acceptability.

    baseline to 12 weeks

Secondary Outcomes (1)

  • Adherence to Exercise Intervention Program: Number of Sessions Completed

    baseline to 12 weeks

Other Outcomes (14)

  • Mean Change in Systolic Blood Pressure

    baseline to 12 weeks

  • Mean Change in Physical Activity

    baseline to 12 weeks

  • Mean Change in Heart Rate

    baseline to 12 weeks

  • +11 more other outcomes

Study Arms (1)

Home-based aerobic exercise

EXPERIMENTAL

Un-supervised exercise will be held 3 times a week for 60 minutes in the participant's home. Those who are unable to do a 60-minute session would instead complete it in two 30-minute sessions to reach the goal of exercising 150 minutes per week.

Behavioral: Home-based aerobic exercise

Interventions

Guidelines for exercise programming (ACSM, 2018) will be followed including a warmup and cool down, progressive and gradual increments in duration, and instruction regarding avoidance of physical activity related injury. The exercise group will receive moderate to vigorous intensity aerobic exercise for 60 minutes per day, three times a week, for 12 weeks. Participants who are unable to do a 60-minute session would instead complete it in two 30-minute sessions. The prescribed intensity will be based on estimated heart rate reserve, calculated using resting heart rate and age-adjusted heart rate maximum (220-age in years). Participants will maintain a minimum heart rate from their specific calculation that will be monitored by Polar Heart Rate straps.

Home-based aerobic exercise

Eligibility Criteria

Age30 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • adults aged 30-55 years
  • exposure to at least one form of threat-related adversity (e.g., exposure to violence; physical abuse) occurring prior to age 10 as documented by retrospective self-report
  • Self-identified Black or African American Race
  • access to high-speed internet
  • sedentary lifestyle (\<60 minutes of PA/week).
  • no difficulties with mobility
  • Does not currently require the use of an assisted walking device
  • Does not have a history of balance difficulties
  • Not currently pregnant or planning to become pregnant in the next 12 months

You may not qualify if:

  • Psychosis
  • Significant suicide risk (i.e., current, active suicidal ideation with a plan)
  • Engaging in moderate-intensity exercise \>=20 min per day, \>=3 times per week
  • Current treatment for cancer
  • Neurological condition (MS, Parkinson's, Dementia, MCI) or brain injury (Stroke)
  • Substance use disorder in the past 3-months
  • Current treatment for congestive heart failure, angina, uncontrolled arrhythmia, deep vein thrombosis (DVT) or other cardiovascular event
  • Myocardial infarction, coronary artery bypass grafting, angioplasty or other cardiac condition in the past year
  • Sensory Impairment that would preclude neuropsychological testing
  • Not fluent in English
  • Travelling consecutively for 2+ weeks during the study
  • uncontrolled hypertension
  • Insulin-Dependent Diabetes Mellitus
  • Self-identified race anything other than Black or African American
  • Currently pregnant or planning to become pregnant in the next 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Sennott Square

Pittsburgh, Pennsylvania, 15220-2505, United States

Location

University of the West Indies

Kingston, Jamaica

Location

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Results Point of Contact

Title
Kirk Erickson, Director of Translational Neuroscience
Organization
AdventHealth Research Institute

Study Officials

  • Kirk I Erickson, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: A single group assigned a remote exercise intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 8, 2021

First Posted

June 11, 2021

Study Start

January 4, 2022

Primary Completion

May 3, 2023

Study Completion

May 30, 2023

Last Updated

June 6, 2024

Results First Posted

June 6, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

The data from this study will be made available to outside investigators under a data-sharing agreement. The data will be available to outside investigators after publication of the primary aims and at completion of quality control assessments and data organization. The investigators expect that the data from this study will result in interest from internal and external investigators for secondary analysis and ancillary projects.

Shared Documents
STUDY PROTOCOL, CSR, ANALYTIC CODE
Time Frame
Will be made available after study investigators have published summary data and primary aims results. Will be available for unlimited amount of time.
Access Criteria
Data requests will be approved by the PI and Co-PIs.

Locations